Sovihep 400mg Tablets
Sovihep (sofosbuvir 400mg) is available in tablets with a daily dosage of 400 mg. The package contains 28 tablets, which, subject to the recommended single intake per day, is acceptable for 4 weeks of standard antiviral treatment. Depending on the period of the course of therapy (12 or 24 weeks), such packages need 3 or 6. Before taking Sovihep 400 mg, you should carefully read the official instructions for its use to avoid the appearance of its possible side effects. Since Sofosbuvir is not used for immunotherapy, the implication for its use is the treatment of hepatitis C 2-6 genotypes in combination with Dacihep, which corresponds to 400 mg of Sofosbuvir and 60 mg of Daclatasvir. Combined treatment with these drugs is well tolerated by most patients. In rare cases, dyspeptic phenomena (nausea, vomiting, colic), dizziness, headaches, tinnitus, allergic reactions (rash, itching), minor depend may occur. As a rule, side effects appear only at the beginning of therapy and are not so pronounced as to cancel treatment. Before receiving “SOVIHEP 400MG TABLET PRICE” from India, you should carefully read the section of the instructions for use, which relates to its drug interaction with other medicines. If a patient is forced to take any of the prohibited drugs against the background of antiviral therapy, he should always consult a doctor about the possibility of his temporary cancellation or replacement.
Sovihep tablet from India
Sovihep (Sofosbuvir) from the Indian company Zydus is a generic version of the original American “Sovaldi”. As in the American original, each tablet “Sovihep” from India contains 400 mg of active ingredient, and in each package – 28 tablets. In the free sale in Russia, the generic “Sovaldi” from Zydus cannot be purchased. This is due to the fact that in accordance with the conditions set by Gilead to licensees, the sale of generic drugs with Sofosbuvir is allowed only in those countries that are included in the special list. In this list, Russia is not included, so in India pharmacies, you can buy only the original “Sovaldi” from the company Gilead. The situation is similar with the generic Daklinza – “Dacihep“
For most hepatitis C patients, treatment with original antiviral medicines is not available. For these patients, there are three options for purchasing generics from India: Drug purchase directly in Indian pharmacies. However, considering how much a ticket costs to India and back, not counting the cost of the medication itself, this option cannot be considered real.
Acquisition of drugs in pharmacies in India on the Internet. This option is more attractive for the India buyer, but it also has many shortcomings. Indian pharmacies do not sell medicines for cash on delivery: 100% prepayment is required, and in this case, there is a risk of being deceived. In addition, the cost of the drug does not include shipping from India. Ultimately, the initial cost of the drug can grow by 50% or more. Order of generics of Indian production on the websites of companies that supply drugs from India under direct contracts. Having made an order on the site, you can get real Indian Generic Drugs at an affordable price.
In order not to purchase a fake, ordering medicines from India on the sites of Indian suppliers, you need to carefully consider their choice: to examine the seller’s website, the documents presented on it, visit the official website of the drug manufacturer (Zydus Heptiza from India) and compare the information obtained. It will not be superfluous to register at specialized forums, where you can get acquainted with the reviews of patients who bought and treated with Indian generics and also ask them a question.
Avoid ordering on sites with a prepayment. Before paying for the purchase you need to make sure of the quality of the medicine. To do this, you need to know how to distinguish the original from a fake: on the website of a generic producer or other information resource, familiarize yourself with the appearance and description of the characteristics of the package, the jar and the tablets themselves, and after obtaining the drug, compare them with the official description.
Medicines are taken by the patient, whether they are original or generic, should be not only genuine but also suitable for use by the expiry date.
To avoid losing the effectiveness of Sovihep and Dacihep drugs during the course of therapy, you need to know how to store them correctly. The instructions for use indicate that the medicines should be stored at a temperature of + 15 ° C to + 30 ° C and relative humidity not higher than 75%, avoiding direct sunlight. A shelf life of the tablets is two years, but despite the long shelf life it is better not to open the jar with the medicine without needing to open it for more than 2 months.
The drug “Sovihep” from the pharmaceutical company “Zydus Heptiza” is a licensed generic “Sofosbuvir”. It is manufactured using the unique technology developed by Gilead Sciences in 2013. Generic in its therapeutic properties is completely equivalent to the original drug, which is why it is often used in complex HCV therapy.
The company “Zydus Heptiza” is one of the largest integrated suppliers of Sofosbuvir, Ledipasvir, and Daclatasvir in 91 countries in Europe and Asia. You can buy medicines on the website of the official supplier of anti-hepatitis drugs or the manufacturer.
Where can I buy Sovihep?
In pharmacies, the drug is not sold because the patent holder banned the export of budget Indian generics to European countries. To purchase the best use of online stores, which have a good set of Indian antiviral medications?
If you do not know which store to contact in order to buy With Sovihep, feel free to call us. You do not even have to make a prepayment to receive the necessary medications. All calculations are carried out only after the delivery of the goods and its verification for the authenticity and integrity of the package. Be sure to ask the operator at the time of purchase that there would be a printed instruction of Sovihep in India with the box of the goods.
Do not forget, hepatitis C is an insidious disease that is accompanied by various complications. To avoid this, do not delay the beginning of therapy; the sooner you start treatment, the more likely it is to have a favorable outcome without relapse.
Sofosbuvir tablets 400 mg price in India
Sofosbuvir, which is the basis of the Sovihep drug, is the nucleotide analog of the inhibitor of the viral enzyme RNA polymerase. When Sofosbuvir is exposed to the RNA polymerase of the virus, the process of copying of ribonucleic acid (RNA), which is the carrier of the viral genetic information, is blocked. Blocking replication leads to inhibition of the process of propagation of the pathogen.
Having shown a high specific activity against the hepatitis C virus, Sofosbuvir 400mg become the leader in the therapy of this infectious pathology and began to be used in all treatment regimens as a basic antiviral substance. In addition to a good therapeutic result, the big advantage of Sofosbuvir is the small number of side effects that it can cause.
In immunotherapy, Sofosbuvir is not used, because the hepatitis C virus quickly mutates and adapts to it. To avoid viral breakthroughs or relapses, Sofosbuvir for the treatment of hepatitis C is always combined with other antiviral substances. The greatest efficacy of Sofosbuvir is shown in combination with direct antiviral substances having a different mechanism of action – inhibitors of viral proteins (Velpatasvir, Daclatasvir, ledipasvir).
For the convenience of use and cheapening of the drug company, Zydus produces combined products with Ledihep (Ledihep) and with Velpatasvir (Sovihep V). Daclatasvir from Zydus is produced as a mono-drug Dacihep. The release of this drug in the form of a separate brand is related to who is the manufacturer of the original drug with Daclatasvir – “Daklinza.” The license for the release of the generic “Daklinza” was purchased by the Indian firm Zydus Heptiza from another American company, the creator of Daclatasvir,
The effectiveness of treatment with combinations of generics is in the zone of statistical reliability of the results of therapy with the original medications on the basis of which they are produced. So, the effectiveness of the combination of “Sovihep” and “Dacihep” for the treatment of Hepatitis C3 genotype with Duration of treatment of 12 weeks course reaches 96%, as with the combination of “Sovaldi” and “Daklinza.” Reviews of those patients who took Zydus generics for the treatment of hepatitis C, confirm this.
In fact, what results from the received medications will be obtained, no longer depends on the originality of the medicine or the manufacturer of the medicament, but on the correctness of the appointment of the therapeutic combination.
Comments of physicians who prescribed a therapeutic combination of Sofosbuvir and Daclatasvir in hepatitis C eloquently prove the high efficiency of Sovihep and Dacihep from Zydus. “Sovihep” and “Dacihep” from India, according to the patients treated, are well tolerated and give good results: almost all patients who took a combination of these remedies got rid of the hepatitis C virus.
“Zydus Heptiza” – manufacturer of “Sovihep”
The company “Zydus Heptiza” is one of the largest Indian pharmaceutical holdings. It was founded in 1952 and today it is among the 5 largest Asian pharmaceutical companies. In 2013, Zydus Heptiza received a license to issue and sell generic forms of “Sovaldi”, “Ledipasvir” and “Daklinza” from the American developer company “Gilead Sciences”. In 2014, she issued several licensed anti-hepatitis drugs, namely:
- “Sovihep” – analog of “Sovaldi”, which contains the inhibitor of the protein NS5B sofosbuvir;
- “Ledihep” is an analog of the combined preparation “Harvoni”, which contains two active substances: sofosbuvir and ledipasvir;
- “Sovihep V” is an analog of “Daklinza”, which contains the inhibitor of the protein NS5B Daclatasvir.
Zydus Heptiza is the largest integrated pharmaceutical supplier of anti-hepatitis drugs.
Medicines are manufactured using technology that was developed by an American developer company. According to their pharmaceutical characteristics, they are completely equivalent to the original anti-hepatitis drugs. After the release of generics, the Indian manufacturer signed an agreement with Gilead Sciences to export pharmaceutical products to 91 countries, including India.